Drug shortage: Fentanyl Citrate Injection (FENTANYL CITRATE)
FDA lists 20 presentations as Current. Availability: Unavailable (3), Limited Availability (3), Available (14). Reason: Other; Demand increase for the drug. Companies: Hospira, Inc., a Pfizer Company, Hikma Pharmaceuticals USA, Inc., Fresenius Kabi USA, LLC.
- Published by source
- 2012-01-01
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Hospira, Inc., a Pfizer Company
- Products
- Fentanyl Citrate Injection FENTANYL CITRATE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released.
- Inventory available in vial presentations.
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2012-01-01
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #878 | new | 2026-10-22 | 46c67592d2de…527ef4 | b0d267e46f02…842c8b |
Chain head: #1076 8ad5adc30b9b…88ce20